U-48800 is an opioid analgesic drug analog of originally U-47700, just added one methylene on the benzene ring, at the same time, 2,4-dichlorophenyl replaced the 3,4-dichlorophenyl. U-48800 is selective for the ยต-opioid receptor, having around 7.5 x the potency of morph in animal models.
he NSO u-48800 [transโ2โ(2,4โdichlorophenyl)โNโ2โ(dimethylamino)cyclohexyl)โNโmethylacetamide, monohydrochloride] appeared in 2017 for the first time on the market. Together with its regioisomer Uโ51754 (metheneโUโ47700), which was also described as an NSO. It belongs to the soโcalled Uโdrugs and is structurally nonโrelated to classical opioids as morphine and fentanyl. u-48800 receptor affinity studies were not yet performed, but based on the analogy to Uโ51754, comparable pharmacological effects are likely.
Due to a higher affinity to the ฮบโreceptor in comparison to the ฮผโreceptor, analgesia with fewer unwanted pharmacological effects. Expect Respiratory depression. Solimini et al recently reviewed the pharmacotoxicology of nonโfentanylโderived NSOs. This found u-48800 available as a โresearch chemicalโ; of the opioid analgesic class to replace Uโ47700 and that conventional drug tests do not detect such compounds. Due to the growing number of acute intoxication cases, they encouraged pharmacological, toxicological, and forensic research on these compounds to provide effective detection methods, amongst others.
The Challenge
Diverted prescription opioid analgesics (e.g., oxycodone, hydrocodone, hydromorphone), failed opioid drug candidates (e.g., benzamide derivatives), and various legal and illegal fentanyl analogs (e.g., acetyl fentanyl, furanylfentanyl, carfentanil) constitute the class of New Synthetic Opioids (NSOs), which is currently posing a global public health threat
What does u-48800 do?
Morever, Similar to opioids, cannabinoids produce their effects by interacting with specific receptors, located within different parts of the CNS. In conclusion, cannabinoids regulate how cells communicate โ how they send, receive, or process messages.
Reviews
There are no reviews yet.